Navigation Links
NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR
Date:4/22/2009

DENVER and SAN CARLOS, Calif., April 22 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) presented data today at the American Association for Cancer Research (AACR) 100th Annual Meeting demonstrating that NKTR-105, a novel PEGylated form of docetaxel, has superior antitumor activity, as well as greater and sustained exposure in plasma and tumor tissue, over docetaxel in preclinical models.

In a comparative study of NKTR-105 and docetaxel, NKTR-105 treatment significantly delayed tumor growth as compared to docetaxel (122% v. 48%), which was associated with greater and sustained tumor exposure to docetaxel after NKTR-105 administration. Treatment with NKTR-105 increased docetaxel concentrations in tumors (0.4 to 4-fold higher) and resulted in an improved time-concentration profile (2-fold greater) as compared to docetaxel in a non-small cell lung (H460) mouse xenograft model.

"The encouraging antitumor activity and unique pharmacokinetic profile of NKTR-105 in these data support our ongoing Phase 1 study in patients with refractory solid cancers," said Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer. "We believe NKTR-105 has the potential to offer improved efficacy as well as improved safety and tolerability due to its prolonged half-life and increased uptake by tumor tissue relative to docetaxel. We are excited about the drug's potential to significantly expand therapeutic options for oncologists and patients."

In previous preclinical studies, NKTR-105 demonstrated superior antitumor activity with no neutropenia in multiple tumor models, indicating that NKTR-105 may enable sustained therapeutic levels of docetaxel without the myelosuppression that is a dose-limiting toxicity for this widely-used cancer therapy.

NKTR-105 is currently
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 in Cancer Patients With Refractory Solid Tumors
2. Fish researcher demonstrates first non-visual feeding by African cichlids
3. Harris Corporation Demonstrates Global Medical Imagery Access, Sharing and Collaboration Capabilities
4. Edmond Scientific Company Demonstrates RHIO/HIE Data Security and Privacy Solution for the NHIN at Annual HIMSS Conference, Chicago 09
5. Stanford Study on CyberKnife Radiosurgery for Prostate Cancer Demonstrates 100 Percent PSA Response at 33 months
6. Siemens Demonstrates Workflow Efficiency in Echocardiography at ACC 2009
7. Siemens Demonstrates Flash Speed, Lowest Dose at ACC 2009
8. New published study demonstrates over-the-counter device lowers blood pressure in diabetic patients
9. MU researcher demonstrates non-traditional therapy is effective as pain management
10. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
11. Bay Valleys French Style Dressing Demonstrates Z Trims Value to Private Label and Store Brands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... 2015 , ... Transfinder, a software company based in Schenectady, N.Y., achieved record ... year-over-year for the first six months ended June 30, 2015 compared with the same ... last year’s record-revenue mark of $10.4 million. , “We know what our customers need ...
(Date:7/31/2015)... ... ... Girl Scouts of Historic Georgia and Peach State Health Plan are teaming up ... First" program. Representatives from Peach State Health Plan presented a $10,000 check for the ... parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. We are very proud ...
(Date:7/31/2015)... ... , ... The 2015 ALS Ice Bucket Challenge will officially get underway today ... honor Ice Bucket co-founders Pat Quinn and Pete Frates, the ALS community and Lou ... among the ALS organizations to find treatments and cures for the disease. , ...
(Date:7/31/2015)... ... July 31, 2015 , ... Recently, ... District of Ohio, Western Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive ... experienced spontaneous migration of their Implanon® implants, inability to locate the implants, unsuccessful ...
(Date:7/31/2015)... ... ... The alarm was ringing. Hugh Chatfield, survivor of a severe 1987 brain injury, almost slept ... equipment was set up to depict the newly poured concrete. With a clear view of ... speaks for itself. Chatfield is also a highly praised safety and drug education speaker/comedian. , ...
Breaking Medicine News(10 mins):Health News:Transfinder Closes First Half of 2015 with Record Revenue 2Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3
... Scientists have identified a small family of lab-made proteins ... including the H5N1 avian virus, the 1918 pandemic influenza ... antibodies, identical infection-fighting proteins derived from the same cell ... caused by H5N1 and other influenza A viruses. Because ...
... as Charitable Partner for National Initiative as Part of ... NEWPORT NEWS, Va., Feb. 22 The Patient Advocate ... patient services to tens of thousands of patients every ... because of financial or insurance denials - is pleased ...
... 22 Statement of Eliseo Medina and David Regan, Trustees ... Labor Report that the National Labor Relations Board has blocked ... UHW to weaken their former local. The NLRB also ... after learning that the ousted leaders of UHW had failed ...
... have begun to solve some of the mysteries of ... the genetic codes for all the known strains of ... School of Medicine in Baltimore and colleagues at the ... the viruses and assembled them into a "family tree," ...
... better balance in a slippery situation , , FRIDAY, Feb. ... where the footing is unstable helped train them to ... says a University of Illinois at Chicago study. ... develops fall prevention strategies that can be used in ...
... During the annual Promesa y ... leading Spanish-language radio group, Hispanics across the country opened their ... Jude Children,s Research Hospital (R), one of the world,s premier ... Promesa y Esperanza generated more than $6 million ...
Cached Medicine News:Health News:Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu 2Health News:Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu 3Health News:Scientists identify lab-made proteins that neutralize multiple strains of seasonal and pandemic flu 4Health News:Patient Advocate Foundation Partners with Breakaway from Cancer, Raising Awareness and Funds for Free Services Available to Cancer Patients 2Health News:Patient Advocate Foundation Partners with Breakaway from Cancer, Raising Awareness and Funds for Free Services Available to Cancer Patients 3Health News:Researchers crack the code of the common cold 2Health News:Researchers crack the code of the common cold 3Health News:Researchers crack the code of the common cold 4Health News:Adapting Gait May Help Elderly Avoid Falls 2Health News:Hispanics Across the Country Pledge More Than $6 Million During Univision Radio Event to Help St. Jude Fight Childhood Cancer 2Health News:Hispanics Across the Country Pledge More Than $6 Million During Univision Radio Event to Help St. Jude Fight Childhood Cancer 3
(Date:7/31/2015)... Pa. , July 31, 2015 ... fully integrated specialty pharmaceutical company focused on developing, ... the closing of its previously announced underwritten public ... at a public offering price of $11.25 per ... offering included 1,000,000 shares issued upon the exercise ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
(Date:7/30/2015)... 30, 2015  ResMed Inc. (NYSE: RMD ) ... 2015.  Revenue for the quarter was $453.1 million, a ... 30, 2014 (a 17 percent increase on a constant ... the quarter ended June 30, 2014.  Diluted earnings per ... quarter ended June 30, 2014.  The ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... Stereotaxis, Inc. (Nasdaq: STXS ) today ... the Company its 100th patent, a major intellectual property ... the "Method and Apparatus for Dynamic Magnetic Field Control ... commitment to innovate and protect its leading position in ...
... Calif., Sept. 20 Questcor Pharmaceuticals, Inc. (Nasdaq: ... UBS Global Life Sciences Conference on Wednesday, September 22, 2010 ... Bailey, President and Chief Executive Officer, will discuss the Company,s ... Time. Attendance at this conference is by invitation ...
Cached Medicine Technology:Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent 2Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent 3Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent 4
... Tamtron PowerPath is IMPACs comprehensive ... anatomic pathology laboratories to integrate and ... needs through a single, intuitive software ... more than 350 institutions have proven ...
The most compact revolutionary innovation in hematology. 8 or 18 automated parameter hematology analyzer....
... vision controls all refractor operations ... from the wireless remote control. ... can be loaded into the ... transfer. The illuminated LED heads-up ...
... in clinical color vision tests. It is ... or blue/yellow color vision losses that accompany ... Plaquenil, for example), early optic neuritis, glaucoma, ... is fast and accurate in quantifying congenital ...
Medicine Products: